WISCONSIN STEM CELL SYMPOSIUM

HELD: April 21, 2010
BioPharmaceutical Technology Center, Madison, WI

VIEW PHOTOS

Check out coverage of this event in the Capitol Times.

BROCHURE

OVERVIEW:

Coordinated by the University of Wisconsin Stem Cell & Regenerative Medicine Center, the Waisman Clinical BioManufacturing Facility and the BTC Institute, this symposium brings together world leaders in multidisciplinary areas who are actively working to address key hurdles that we face in advancing stem cell therapeutics into clinical and commercial applications. The symposium will cover key topics in stem cell therapy development including:

• What role does cell line characterization and banking play in supporting the transition of stem cell research into clinical and commercial applications?
• What key issues will the FDA focus on when reviewing applications to move a cell therapeutic into early-stage human clinical trials?
• What key safety issues need to be addressed when moving a stem cell therapy into human clinical trials and how can in vitro and in vivo studies be used to assess risk?
• What lessons have we learned from completed and on-going cell therapeutic clinical trials?
• What challenges will we face in delivering cell therapeutics to patients and how can these challenges be addressed?
• What manufacturing challenges remain for commercial applications involving stem cells?

PRESENTERS:

• Peter Andrews, Ph.D., Arthur Jackson Professor of Medical Science, University of Sheffield
• Robert N. Golden, M.D., Dean, School of Medicine & Public Health, University of Wisconsin-Madison
• Carl E. Gulbrandsen, Ph.D., J.D.,  Director, Wisconsin Alumni Research Foundation
• Derek Hei, Ph.D., Technical Director, Waisman Clinical Biomanufacturing Facility and Principal Investigator, National Stem Cell Bank, University of Wisconsin-Madison
• Lynn Allen-Hoffmann, Ph.D., CEO and President, Stratatech Corporation and Professor, Department of Pathology and Laboratory Medicine, University of Wisconsin – Madison
• Linda F. Hogle, Ph.D., Associate Professor, Medical History & Bioethics, University of Wisconsin–Madison
• Tim Kamp, M.D., Ph.D., Director, Stem Cell & Regenerative Medicine Center, University of Wisconsin–Madison
• Raymond Lund, Ph.D., Professor, Casey Eye Institute, Oregon Health Science University
• Brent McCright, Ph.D., Research Biologist, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
• Thomas B. Okarma, Ph.D., M.D., President, Chief Executive Officer, Geron
• Amish Raval, M.D., Assistant Professor, School of Medicine & Public Health, University of Wisconsin – Madison
• Peter Zandstra, Ph.D., Professor and Canada Research Chair of Stem Cell Bioengineering, University of Toronto

PRESENTER BIOSKETCHES

PRESENTER ABSTRACTS

ARCHIVE